These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 25378667)
21. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053 [TBL] [Abstract][Full Text] [Related]
22. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging. Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474 [TBL] [Abstract][Full Text] [Related]
23. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study. Dolezal O; Gabelic T; Horakova D; Bergsland N; Dwyer MG; Seidl Z; Krasensky J; Ramasamy DP; Vaneckova M; Havrdova E; Zivadinov R Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S42-8. PubMed ID: 24321154 [TBL] [Abstract][Full Text] [Related]
24. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis. Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637 [TBL] [Abstract][Full Text] [Related]
25. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [TBL] [Abstract][Full Text] [Related]
26. Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. Miki Y; Grossman RI; Udupa JK; van Buchem MA; Wei L; Phillips MD; Patel U; McGowan JC; Kolson DL Radiology; 1999 Mar; 210(3):769-74. PubMed ID: 10207480 [TBL] [Abstract][Full Text] [Related]
27. Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis. Foster M; Zivadinov R; Weinstock-Guttman B; Tamaño-Blanco M; Badgett D; Carl E; Ramanathan M J Neuroimmunol; 2012 Feb; 243(1-2):61-8. PubMed ID: 22261546 [TBL] [Abstract][Full Text] [Related]
28. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis. Uher T; Vaneckova M; Krasensky J; Sobisek L; Tyblova M; Volna J; Seidl Z; Bergsland N; Dwyer MG; Zivadinov R; De Stefano N; Sormani MP; Havrdova EK; Horakova D Mult Scler; 2019 Apr; 25(4):541-553. PubMed ID: 29143562 [TBL] [Abstract][Full Text] [Related]
29. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253 [TBL] [Abstract][Full Text] [Related]
30. Brain volume and fatigue in patients with postpoliomyelitis syndrome. Trojan DA; Narayanan S; Francis SJ; Caramanos Z; Robinson A; Cardoso M; Arnold DL PM R; 2014 Mar; 6(3):215-20. PubMed ID: 24060387 [TBL] [Abstract][Full Text] [Related]
31. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003 [TBL] [Abstract][Full Text] [Related]